weight loss response to semaglutide in postmenopausal women PDF) with and without hormone therapy use Our Chief Medical Officer, Dr.

This can lead to symptoms such as: A fluttering or pounding heartbeat Shortness of breath Tiredness or reduced ability to exercise It also increases the risk of stroke and heart failure if left unmanaged

If semaglutide is affecting your sleep , discuss timing adjustments with your provider

Eat balanced meals Skipping meals or undereating can worsen cold sensitivity

For healthcare professionals, this approval provides a new treatment option to help us address cardiovascular residual risk that remains for patients on current standard of care. Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, said John Sharretts, director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDAs Center for Drug Evaluation and Research